Coverage Initiated on Developer of Brachytherapy Products for Cancer Treatment

Source: Streetwise Reports   08/22/2018 H.C. Wainwright & Co. analyst Jason Kolbert provided the rationale for investment in this company. In an Aug. 20 research note, Kolbert reported that H.C. Wainwright & Co. initiated coverage on [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.